About 1 result found for searched term "932730-52-4" (0.155 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M58515 | CDDO-TFEA | Keap1-Nrf2 |
| CDDO-Trifluoethyl amide; RTA 404; TP-500 | ||
| CDDO-TFEA (RTA 404; TP-500) is a trifluoroacetamide derivative of CDDO with enhanced ability to cross the blood-brain barrier. CDDO is an Nrf2 activator that inhibits proliferation and induces differentiation and apoptosis in various cancer cells. CDDO-TFEA can enhance Nrf2 expression and signaling in various neurodegenerative disease models. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
